Drug Profile
Interferon-alpha-2a biosimilar - Nanogen
Alternative Names: Feronsure; Recombinant interferon alfa – 2a - NanogenLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Nanogen Biopharmaceutical Co
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Immunostimulants; Interferon alfa 2a stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis B; Hepatitis C; Liver cirrhosis
Most Recent Events
- 04 Mar 2014 Launched for Cirrhosis in Vietnam (Parenteral)
- 04 Mar 2014 Launched for Hepatitis B in Vietnam (Parenteral) prior to March 2014
- 04 Mar 2014 Launched for Hepatitis C in Vietnam (Parenteral)